Transtracheal Systems, Inc

Form 483 issued September 17, 2020 · Englewood, Colorado

Inspection
Sep 2 – Sep 17, 2020
Investigator
Christine I. Shaw
Observations
6
Pages
11
FEI number
1721097

In short: On September 17, 2020, FDA issued a Form 483 with 6 observations to Transtracheal Systems, Inc in Englewood, Colorado (FEI 1721097) after an inspection that ran Sep 2 – Sep 17, 2020. The investigator was Christine I. Shaw. Most observations concern production & process controls and cAPA.

At a glance

Production & process controls and capa account for 5 of 6 observations.

Production & process controls3
CAPA2
Records & documents1

What FDA observed

Preview: the opening words of each observation
  1. 01

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  2. 02

    Procedures for corrective and preventive action have…

  3. 03

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

  4. 04

    Procedures to control labeling activities have…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Transtracheal Systems, Inc?

FDA listed 6 observations on this Form 483, mostly about production & process controls, cAPA and records & documents. The opening words of each observation are shown on this page.

Who inspected Transtracheal Systems, Inc?

Christine I. Shaw is named on this Form 483, for the inspection of Sep 2 – Sep 17, 2020. Each investigator has a profile showing what they cite most.

When was Transtracheal Systems, Inc inspected by FDA?

The inspection ran Sep 2 – Sep 17, 2020, and the Form 483 is dated September 17, 2020.

How do I get the full Form 483 for Transtracheal Systems, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free